Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin ...

Recursion, Roche and Genentech unveiled the latest product of their nearly four-year artificial intelligence drug discovery collaboration. GSK ’s Blenrep was approved by the FDA for treatment of ...

The live event in Nashville, Tenn., featured 60-plus leaders, and also honored several companies with awards for supply chain excellence.

Before being discontinued, the P2X7 receptor blocker had cleared a master protocol study in chronic pain, though Eli Lilly ...

As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn acquisition of ...

Q3 2025 Earnings Call Transcript October 29, 2025 NiSource Inc. misses on earnings expectations. Reported EPS is $0.19 EPS, ...

Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Euro US Dollar, US Dollar Japanese Yen, Nasdaq 100, Gold Spot US Dollar. Read 's Market Analysis on Investing.com ...

In a week filled with high-stakes earnings reports, major tech companies are taking center stage, influencing market dynamics and investor sentiment. The latest results from industry giants like ...

Eli Lilly And Company ( ($LLY) ) has released its Q3 earnings. Here is a breakdown of the information Eli Lilly And Company presented to its ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

As of 10 AM Eastern Time, the S&P 500 slipped 0.2%, the Dow Jones Industrial Average was up 0.5%, and the Nasdaq Composite ...